Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

BAĞCIOĞLU, MURAT; Surcel, Cristian; Ozcan, Serkan; Mirvald, Cristian; Karagoz, Mehmet; Karadag, Mert; HURİ, EMRE; Sarica, Kemal

doi:10.4081/aiua.2017.4.282

Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

BAĞCIOĞLU M., Surcel C., Ozcan S., Mirvald C., Karagoz M. A., Karadag M. A., ...Daha Fazla

ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, cilt.89, sa.4, ss.282-286, 2017 (ESCI, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 89 Sayı: 4
Basım Tarihi: 2017
Doi Numarası: 10.4081/aiua.2017.4.282
Dergi Adı: ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
Sayfa Sayıları: ss.282-286
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Androgen deprivation therapy (ADT) is commonly used as a first-line treatment for locally advanced and metastatic prostatic cancer (Pca). There is no consensus about which alternative treatment should be used after the failure of initial ADT. We aimed to investigate the effect of changes in treatment on PSA and testosterone levels.